Refine Search
(88)
(286)
(506)
(531)

NEW Alopecia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alopecia - Pipeline Review, H1 2019’, provides an overview of the Alopecia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alopecia, complete with anal...

NEW Pulmonary Arterial Hypertension - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2019’, provides an overview of the Pulmonary Arterial Hypertension pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

NEW Myocardial Infarction - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H1 2019’, provides an overview of the Myocardial Infarction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for My...

NEW Insulin Resistance - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2019’, provides an overview of the Insulin Resistance pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insulin ...

NEW Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2019’, provides an overview of the Prader-Willi Syndrome (PWS) pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

NEW Urinary Incontinence - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H1 2019’, provides an overview of the Urinary Incontinence pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Urin...

NEW Restenosis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Restenosis - Pipeline Review, H1 2019’, provides an overview of the Restenosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Restenosis, complete wit...

NEW Chemotherapy Induced Neutropenia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

NEW Diarrhea - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H1 2019’, provides an overview of the Diarrhea pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with anal...

NEW Fibromyalgia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2019’, provides an overview of the Fibromyalgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibromyalgia, comple...

NEW Anthrax - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2019’, provides an overview of the Anthrax pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysi...

NEW Ischemia Reperfusion Injury - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ischemia Reperfusion Injury - Pipeline Review, H1 2019’, provides an overview of the Ischemia Reperfusion Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

NEW Alcohol Addiction - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H1 2019’, provides an overview of the Alcohol Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alcohol Ad...

NEW Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019’, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline landscape.

The report provides ...

NEW Batten Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H1 2019’, provides an overview of the Batten Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Batten Disease, ...

NEW Diabetic Gastroparesis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Gastroparesis - Pipeline Review, H1 2019’, provides an overview of the Diabetic Gastroparesis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

NEW Encephalomyelitis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalomyelitis - Pipeline Review, H1 2019’, provides an overview of the Encephalomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalom...

NEW Dementia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2019’, provides an overview of the Dementia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dementia, complete with anal...

NEW Myocarditis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myocarditis - Pipeline Review, H1 2019’, provides an overview of the Myocarditis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Myocarditis, complete ...

NEW Liver Cirrhosis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Cirrhosis - Pipeline Review, H1 2019’, provides an overview of the Liver Cirrhosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Liver Cirrhosi...

NEW Trigeminal Neuralgia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Trigeminal Neuralgia - Pipeline Review, H1 2019’, provides an overview of the Trigeminal Neuralgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Trig...

NEW Genital Herpes - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H1 2019’, provides an overview of the Genital Herpes pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Genital Herpes, ...

NEW Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019’, provides an overview of the Bacillary Dysentery (Shigellosis) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

NEW Osteomyelitis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteomyelitis - Pipeline Review, H1 2019’, provides an overview of the Osteomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteomyelitis, com...

NEW African Trypanosomiasis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H1 2019’, provides an overview of the African Trypanosomiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

NEW Gonorrhea - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gonorrhea - Pipeline Review, H1 2019’, provides an overview of the Gonorrhea pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gonorrhea, complete with a...

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape.

The report provides comprehensive information on the thera...

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

The report provide...

Constipation - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2019’, provides an overview of the Constipation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Constipation, comple...

Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2019’, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline landscape.

The report provides comprehe...

Primary Sclerosing Cholangitis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H1 2019’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Colitis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2019’, provides an overview of the Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysi...

Warts - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Warts - Pipeline Review, H1 2019’, provides an overview of the Warts pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Warts, complete with analysis by s...

Plague - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Plague - Pipeline Review, H1 2019’, provides an overview of the Plague pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis b...

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2019’, provides an overview of the Ventilator Associated Pneumonia (VAP) pipeline landscape.

The report provides comprehensive information on the thera...

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019’, provides an overview of the Hospital Acquired Pneumonia (HAP) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Erectile Dysfunction - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Erectile Dysfunction - Pipeline Review, H1 2019’, provides an overview of the Erectile Dysfunction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Erec...

Male Hypogonadism - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Male Hypogonadism - Pipeline Review, H1 2019’, provides an overview of the Male Hypogonadism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Male Hypog...

Sarcopenia - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2019’, provides an overview of the Sarcopenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete wit...

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019’, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape.

The report provides comprehensive information on the therapeut...

Myasthenia Gravis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2019’, provides an overview of the Myasthenia Gravis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Myasthenia...

Amyloidosis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2019’, provides an overview of the Amyloidosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete ...

Hypotension - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypotension - Pipeline Review, H1 2019’, provides an overview of the Hypotension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypotension, complete ...

Thromboembolism - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2019’, provides an overview of the Thromboembolism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thromboembolis...

Left Ventricular Dysfunction - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H1 2019’, provides an overview of the Left Ventricular Dysfunction pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Dilated Cardiomyopathy - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2019’, provides an overview of the Dilated Cardiomyopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019’, provides an overview of the Microscopic Polyangiitis (MPA) pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Restless Legs Syndrome - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Restless Legs Syndrome - Pipeline Review, H1 2019’, provides an overview of the Restless Legs Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Tourette syndrome - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H1 2019’, provides an overview of the Tourette Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tourette S...

Fatigue - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fatigue - Pipeline Review, H1 2019’, provides an overview of the Fatigue pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysi...

Obsessive-Compulsive Disorder - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2019’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H1 2019’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cluster Headache Syndrome - Pipeline Review, H1 2019’, provides an overview of the Cluster Headache Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Hyperalgesia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H1 2019’, provides an overview of the Hyperalgesia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperalgesia, comple...

Encephalitis - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Encephalitis - Pipeline Review, H1 2019’, provides an overview of the Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Encephalitis, comple...

Sedation - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sedation - Pipeline Review, H1 2019’, provides an overview of the Sedation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sedation, complete with anal...

Hepatic Encephalopathy - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatic Encephalopathy - Pipeline Review, H1 2019’, provides an overview of the Hepatic Encephalopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Primary Biliary Cirrhosis - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Biliary Cirrhosis - Pipeline Review, H1 2019’, provides an overview of the Primary Biliary Cirrhosis pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019’, provides an overview of the Functional (Non Ulcer) Dyspepsia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2019’, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Urem...

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2019’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Typhoid Fever - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2019’, provides an overview of the Typhoid Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Typhoid Fever, com...

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2019’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape.

The report provides comprehensive information on the therape...

Lyme Disease - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H1 2019’, provides an overview of the Lyme Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lyme Disease, comple...

Smallpox - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Smallpox - Pipeline Review, H1 2019’, provides an overview of the Smallpox pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Smallpox, complete with anal...

Bacterial Vaginosis - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2019’, provides an overview of the Bacterial Vaginosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bacter...

Streptococcus pyogenes Infections - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Streptococcus pyogenes Infections - Pipeline Review, H1 2019’, provides an overview of the Streptococcus pyogenes Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Cholera - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2019’, provides an overview of the Cholera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysi...

Botulism - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2019’, provides an overview of the Botulism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Botulism, complete with anal...

Mumps - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2019’, provides an overview of the Mumps pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by s...

Degenerative Disc Disease - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H1 2019’, provides an overview of the Degenerative Disc Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Birch Pollen Allergy - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Birch Pollen Allergy - Pipeline Review, H1 2019’, provides an overview of the Birch Pollen Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Birc...

House Dust Mite Allergy - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H1 2019’, provides an overview of the House Dust Mite Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Phenylketonuria (PKU) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Phenylketonuria (PKU) - Pipeline Review, H1 2019’, provides an overview of the Phenylketonuria (PKU) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ph...

Nocturia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2019’, provides an overview of the Nocturia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nocturia, complete with anal...

Iron Deficiency Anemia - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H1 2019’, provides an overview of the Iron Deficiency Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Secondary Hyperparathyroidism - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2019’, provides an overview of the Secondary Hyperparathyroidism pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Pressure Ulcers - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pressure Ulcers - Pipeline Review, H1 2019’, provides an overview of the Pressure Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pressure Ulcer...

Hidradenitis Suppurativa - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hidradenitis Suppurativa - Pipeline Review, H1 2019’, provides an overview of the Hidradenitis Suppurativa pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Venous Leg Ulcers (Crural Ulcer) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2019’, provides an overview of the Venous Leg Ulcers (Crural ulcer) pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Otitis Media - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H1 2019’, provides an overview of the Otitis Media pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Otitis Media, comple...

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Pipeline Review, H1 2019’, provides an overview of the Nasopharyngitis (Common Cold) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2019’, provides an overview of the Opioid-Induced Constipation (OIC) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2019’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape.

The report provides comprehensive information on the therape...

Cervical Cancer - Pipeline Review, H2 2018

  • $2,000
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H2 2018’, provides an overview of the Cervical Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cervical Cance...

Colorectal Cancer - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H2 2018’, provides an overview of the Colorectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colorectal...

Melanoma - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Melanoma - Pipeline Review, H2 2018’, provides an overview of the Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Melanoma, complete with anal...

Pancreatic Cancer - Pipeline Review, H2 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H2 2018’, provides an overview of the Pancreatic Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pancreatic...

Diabetic Foot Ulcers - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H2 2018’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Diabetic Neuropathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2018’, provides an overview of the Diabetic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diabet...

Radiodermatitis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Radiodermatitis - Pipeline Review, H2 2018’, provides an overview of the Radiodermatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Radiodermatiti...

Irritable Bowel Syndrome - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H2 2018’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Gastritis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastritis - Pipeline Review, H2 2018’, provides an overview of the Gastritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastritis, complete with a...

Peritonitis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritonitis - Pipeline Review, H2 2018’, provides an overview of the Peritonitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritonitis, complete ...

Systemic Mastocytosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H2 2018’, provides an overview of the Systemic Mastocytosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sy...

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018’, provides an overview of the Herpes Labialis (Oral Herpes) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Tularaemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H2 2018’, provides an overview of the Tularaemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tularaemia, complete wit...

Aspergillosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H2 2018’, provides an overview of the Aspergillosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Aspergillosis, com...

Cryptosporidiosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptosporidiosis - Pipeline Review, H2 2018’, provides an overview of the Cryptosporidiosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptospor...

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018’, provides an overview of the Progressive Multifocal Leukoencephalopathy pipeline landscape.

The report provides comprehensive information on...